BI
CTMX icon

BVF Inc’s CytomX Therapeutics CTMX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-5,228,461
Closed -$3.32M 46
2025
Q1
$3.32M Hold
5,228,461
0.14% 43
2024
Q4
$5.39M Hold
5,228,461
0.18% 44
2024
Q3
$6.17M Hold
5,228,461
0.18% 39
2024
Q2
$6.38M Sell
5,228,461
-1,367,340
-21% -$1.67M 0.18% 42
2024
Q1
$14.4M Hold
6,595,801
0.4% 36
2023
Q4
$10.2M Hold
6,595,801
0.26% 48
2023
Q3
$8.51M Hold
6,595,801
0.23% 48
2023
Q2
$11.3M Hold
6,595,801
0.32% 45
2023
Q1
$9.96M Hold
6,595,801
0.36% 48
2022
Q4
$10.6M Hold
6,595,801
0.45% 49
2022
Q3
$9.56M Buy
6,595,801
+792,101
+14% +$1.15M 0.4% 52
2022
Q2
$10.6M Hold
5,803,700
0.51% 50
2022
Q1
$15.5M Hold
5,803,700
0.62% 43
2021
Q4
$25.1M Buy
+5,803,700
New +$25.1M 0.91% 31
2021
Q2
Sell
-5,576,471
Closed -$43.1M 71
2021
Q1
$43.1M Hold
5,576,471
1.62% 22
2020
Q4
$36.5M Buy
5,576,471
+2,016,749
+57% +$13.2M 1.44% 25
2020
Q3
$23.7M Buy
3,559,722
+444,185
+14% +$2.95M 1.29% 26
2020
Q2
$26M Sell
3,115,537
-806,436
-21% -$6.72M 1.6% 24
2020
Q1
$30.1M Buy
3,921,973
+3,155,825
+412% +$24.2M 2.8% 13
2019
Q4
$6.37M Sell
766,148
-1,111,000
-59% -$9.23M 0.48% 38
2019
Q3
$13.9M Buy
1,877,148
+3,531
+0.2% +$26.1K 1.46% 23
2019
Q2
$21M Buy
1,873,617
+675,617
+56% +$7.58M 2.3% 14
2019
Q1
$12.9M Buy
+1,198,000
New +$12.9M 1.44% 25
2018
Q1
Sell
-1,124,483
Closed -$23.7M 44
2017
Q4
$23.7M Sell
1,124,483
-1,106,415
-50% -$23.4M 2.86% 11
2017
Q3
$40.5M Buy
2,230,898
+203,900
+10% +$3.7M 5.15% 8
2017
Q2
$31.4M Buy
2,026,998
+222,323
+12% +$3.45M 4.88% 7
2017
Q1
$31.2M Buy
1,804,675
+1,249,869
+225% +$21.6M 5.3% 6
2016
Q4
$6.1M Sell
554,806
-37,007
-6% -$407K 1.23% 20
2016
Q3
$9.28M Sell
591,813
-14,325
-2% -$225K 1.75% 16
2016
Q2
$6.19M Hold
606,138
1.32% 21
2016
Q1
$7.82M Sell
606,138
-2,710
-0.4% -$35K 1.93% 19
2015
Q4
$12.7M Buy
+608,848
New +$12.7M 2.17% 16